Literature DB >> 22903847

From ulcer to infection: an update on clinical practice and adjunctive treatments of diabetic foot ulcers.

C Abad1, N Safdar.   

Abstract

Foot ulcers are a common complication of diabetes. A fifth of all individuals with diabetes develop a diabetic foot infection and are hospitalized at least once in their lifetime. Standard of care for treatment of diabetic foot ulcers and subsequent infection involves a multimodal, interdisciplinary team approach that includes wound care, systemic antimicrobials, and surgery. However, with the relatively poor outcome for chronic, longstanding ulcers and severe infections, recent research has focused on adjunctive therapies to promote wound healing and repair. This review summarizes the underlying pathology and classification of diabetic ulcers and focuses on recent advances that have important implications for the use of adjunctive therapy for diabetic foot infections.

Entities:  

Year:  2012        PMID: 22903847     DOI: 10.1007/s11908-012-0283-3

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  97 in total

Review 1.  Expert opinion on the management of infections in the diabetic foot.

Authors:  B A Lipsky; E J G Peters; E Senneville; A R Berendt; J M Embil; L A Lavery; V Urbančič-Rovan; W J Jeffcoate
Journal:  Diabetes Metab Res Rev       Date:  2012-02       Impact factor: 4.876

2.  Vacuum-assisted closure: a new method for wound control and treatment: clinical experience.

Authors:  L C Argenta; M J Morykwas
Journal:  Ann Plast Surg       Date:  1997-06       Impact factor: 1.539

3.  Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.

Authors:  G Siami; N Christou; I Eiseman; K J Tack
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

4.  Bacteriological study of diabetic foot infections.

Authors:  Adel Abdulrazak; Zouheir Ibrahim Bitar; Abdullah Ayesh Al-Shamali; Lubna Ahmed Mobasher
Journal:  J Diabetes Complications       Date:  2005 May-Jun       Impact factor: 2.852

5.  A randomized controlled trial of filgrastim for the treatment of hospitalized patients with multilobar pneumonia.

Authors:  S Nelson; A M Heyder; J Stone; M G Bergeron; S Daugherty; G Peterson; N Fotheringham; W Welch; S Milwee; R Root
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

6.  Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.

Authors:  G E Reiber; L Vileikyte; E J Boyko; M del Aguila; D G Smith; L A Lavery; A J Boulton
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

7.  Dose-dependent hyperbaric oxygen stimulation of human fibroblast proliferation.

Authors:  K Brismar; F Lind; G Kratz
Journal:  Wound Repair Regen       Date:  1997 Apr-Jun       Impact factor: 3.617

8.  Effects of hyperbaric oxygen upon S. aureus, Ps. aeruginosa and C. albicans.

Authors:  G L Brown; P D Thomson; J T Mader; J G Hilton; M E Browne; C H Wells
Journal:  Aviat Space Environ Med       Date:  1979-07

9.  Clinical signs of infection in diabetic foot ulcers with high microbial load.

Authors:  Sue E Gardner; Stephen L Hillis; Rita A Frantz
Journal:  Biol Res Nurs       Date:  2009-10       Impact factor: 2.522

10.  Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers.

Authors:  T Kästenbauer; B Hörnlein; G Sokol; K Irsigler
Journal:  Diabetologia       Date:  2002-12-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.